The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has begun a search for a new Executive Director, as Kevin M. Smith leaves as part of a planned retirement. Mr. Smith will remain with CID4 through February 2015 to ensure a smooth and successful transition for CID4’s new leader.

1. FOR IMMEDIATE RELEASE
For more information, contact:
Kevin M. Smith, President & CEO CID4 Maggie Chamberlin Holben, APR
kevin.smith@cid4.com maggie@absolutelypr.com
(720) 859-4047 (303) 984-9801
Kevin M. Smith to Retire as President & CEO of the Colorado
Institute for Drug, Device and Diagnostic Development;
Search Committee Formed to Hire Smith’s Successor
The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has begun a
search for a new Executive Director, as Kevin M. Smith leaves as part of a planned
retirement. Mr. Smith will remain with CID4 through February 2015 to ensure a smooth
and successful transition for CID4’s new leader.
Aurora, CO November 24, 2014 – Kevin M. Smith, President and CEO of the Colorado
Institute for Drug, Device and Diagnostic Development (CID4) since 2010, will retire from
his position as Chief Executive Officer on December 31, 2014. The announcement is made
by Steve Orndorff, PhD, Chairman of the CID4 Board and President & CEO of MicroBiome
Therapeutics, who says the CID4 Board has formed a search committee and that Smith will
be available through February 2015 to assist in a smooth transition for the new Executive
Director.
“With the ongoing changes in the healthcare and life science sectors, CID4 is revisiting how it
can best support our industry,” Orndorff said. “CID4 is well positioned for its future and we
believe the new Executive Director position will strengthen our alignment with the State of
Colorado in our mutual quest to create new jobs and business opportunities within the dynamic
life science sector of advanced industries.”
All inquiries should be directed to the ‘CID4 Search Committee’ at jobs@cid4.com. The
deadline for applications is December 20, 2014. Principals only need apply, please.
About Kevin M. Smith, CID4 President & CEO
Smith was part of the team that founded CID4 in 2009. Prior to
CID4, Smith was President of Gambro, Inc., the U.S. holding
company for Gambro AB, the Sweden-based medical device and
healthcare services company. He started his career with Arthur
Young in New York and was a partner with Ernst & Young, leading
the development of their Colorado life science practice at the time
he left to join Gambro.
-More-

2. FOR IMMEDIATE RELEASE
Page 2
“While I will no longer be leading CID4, I will stay active in the Colorado life science
community through my Board responsibilities at the Colorado BioScience Association, Donor
Alliance and AlloSource, my service on the Centura Health Audit and Corporate Responsibility
Committee and my investment activities at KMG Capital Partners LLC,” Smith said. “CID4’s
success is grounded in the excellent technologies that are being developed in Colorado. We
have invested approximately $3 million into nine early stage companies. Those firms have
gone on to create 85 new jobs and raise an additional $30 million to support the
commercialization of their patient-focused technologies. I am proud to have played a role in
this process.”
About the Colorado Institute for Drug, Device and Diagnostic Development
Founded in 2009, the Colorado Institute for Drug, Device and Diagnostic Development (CID4)
is a 501(c)(3) not-for-profit charitable organization whose mission is to advance the Colorado
bioscience ecosystem through company creation and job growth. Active business management
and capital work in tandem to help bridge the gap between discovery and product development.
CID4 works to identify, fund and actively manage emerging life science technologies. This aim
is achieved via an ongoing technology solicitation process augmented by additional deal flow
sourcing through networked relationships. Active due diligence is provided by CID4
management in consultation with members of the CID4 Technical and Business Advisory
Committee. For more information visit http://CID4.com.